These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17826625)

  • 1. Pharmacokinetic and pharmacodynamic aspects of antibiotic use in high-risk populations.
    Bergman SJ; Speil C; Short M; Koirala J
    Infect Dis Clin North Am; 2007 Sep; 21(3):821-46, x. PubMed ID: 17826625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duration of antibiotic treatment in surgical infections of the abdomen. Pharmacokinetic basis for short courses of antimicrobial therapy.
    Wittmann DH
    Eur J Surg Suppl; 1996; (576):19-23. PubMed ID: 8908464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and the dosage regimen of antimicrobial agents.
    Powers TE; Powers JD
    Ann Rech Vet; 1990; 21 Suppl 1():41S-45S. PubMed ID: 2080846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical implications of antibiotic pharmacokinetic-pharmacodynamic parameters].
    Cohen R
    Arch Pediatr; 2008 Oct; 15 Suppl 2():S53-8. PubMed ID: 19000855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics/pharmacodynamics of antibacterials in the Intensive Care Unit: setting appropriate dosing regimens.
    Scaglione F; Paraboni L
    Int J Antimicrob Agents; 2008 Oct; 32(4):294-301. PubMed ID: 18621508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating pharmacokinetics, pharmacodynamics and pharmacogenomics to predict outcomes in antibacterial therapy.
    Gumbo T
    Curr Opin Drug Discov Devel; 2008 Jan; 11(1):32-42. PubMed ID: 18175265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue penetration of antibacterial agents: how should this be incorporated into pharmacodynamic analyses?
    Theuretzbacher U
    Curr Opin Pharmacol; 2007 Oct; 7(5):498-504. PubMed ID: 17616438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Physiopathologic mechanisms in bacterial infection and antibiotics].
    Lagrange PH
    Pathol Biol (Paris); 1990 Apr; 38(4):239-41. PubMed ID: 2377383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic and pharmacodynamic properties of meropenem.
    Nicolau DP
    Clin Infect Dis; 2008 Sep; 47 Suppl 1():S32-40. PubMed ID: 18713048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamics of antimicrobial agents. Bactericidal and postantibiotic effects.
    Levison ME; Bush LM
    Infect Dis Clin North Am; 1989 Sep; 3(3):415-21. PubMed ID: 2671131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic-pharmacodynamic crisis in the elderly.
    ElDesoky ES
    Am J Ther; 2007; 14(5):488-98. PubMed ID: 17890940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Difficult to treat infections" pharmacokinetic and pharmacodynamic factors--a review.
    Schierholz JM; Beuth J; Pulverer G
    Acta Microbiol Immunol Hung; 2000; 47(1):1-8. PubMed ID: 10735184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antibiotics dosing strategies in chronic kidney disease].
    Bourquin V
    Rev Med Suisse; 2007 Oct; 3(128):2280-2, 2284-8. PubMed ID: 17985604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial Pharmacokinetics and Pharmacodynamics.
    Jarrell AS; Kruer RM; Johnson D; Lipsett PA
    Surg Infect (Larchmt); 2015 Aug; 16(4):375-9. PubMed ID: 26207398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentration-effect relationship for antimicrobial drugs.
    Mini E; Novelli A; Periti P
    J Chemother; 1991 Jan; 3 Suppl 1():149-54. PubMed ID: 12041751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can pharmacokinetic-pharmacodynamic parameters provide dosing regimens that are less vulnerable to resistance?
    Courvalin P
    Clin Microbiol Infect; 2008 Nov; 14(11):989-94. PubMed ID: 19040470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Optimizing pharmacotherapeutic aspects of pharmacokinetic and pharmacodynamic drug properties in the elderly].
    Orzechowska-Juzwenko K
    Przegl Lek; 1998; 55(11):607-10. PubMed ID: 10216376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combating resistance: application of the emerging science of pharmacokinetics and pharmacodynamics.
    Jacobs MR
    Int J Antimicrob Agents; 2007 Dec; 30 Suppl 2():S122-6. PubMed ID: 17936592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic issues for antibiotics in the critically ill patient.
    Roberts JA; Lipman J
    Crit Care Med; 2009 Mar; 37(3):840-51; quiz 859. PubMed ID: 19237886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinectics of vancomycin and amikacin in the subeschar tissue fluid in patients with severe burn.
    Yang RH; Rong XZ; Hua R; Zhang T
    Burns; 2009 Feb; 35(1):75-9. PubMed ID: 18789586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.